Folgen
Vincent Lemaire
Vincent Lemaire
Principal Scientist, Clinical Pharmacology, Systems Modeling Lead, Genentech
Bestätigte E-Mail-Adresse bei gene.com
Titel
Zitiert von
Zitiert von
Jahr
Modeling the interactions between osteoblast and osteoclast activities in bone remodeling
V Lemaire, FL Tobin, LD Greller, CR Cho, LJ Suva
Journal of theoretical biology 229 (3), 293-309, 2004
5512004
Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy
A Rotte, JY Jin, V Lemaire
Annals of Oncology 29 (1), 71-83, 2018
3362018
Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process
V Lemaire, J Belair, P Hildgen
International journal of pharmaceutics 258 (1-2), 95-107, 2003
1582003
Numerical bifurcation analysis of delay differential equations arising from physiological modeling
K Engelborghs, V Lemaire, J Belair, D Roose
Journal of mathematical biology 42, 361-385, 2001
1152001
Sequential recruitment and combinatorial assembling of multiprotein complexes in transcriptional activation
V Lemaire, CF Lee, J Lei, R Métivier, L Glass
Physical review letters 96 (19), 198102, 2006
372006
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations
V Lemaire, CS Shemesh, A Rotte
Journal of Experimental & Clinical Cancer Research 40 (1), 311, 2021
342021
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies
V Lemaire, DR Cox
Bulletin of Mathematical Biology, 1–48, 2018
102018
Spatial effects in modeling pharmacokinetics of rapid action drugs
P Lafrance, V Lemaire, F Varin, F Donati, J Bélair, F Nekka
Bulletin of mathematical biology 64 (3), 483-500, 2002
102002
From cold to hot: changing perceptions and future opportunities for quantitative systems pharmacology modeling in cancer immunotherapy
V Lemaire, D Bassen, M Reed, R Song, S Khalili, YT Lien, L Huang, ...
Clinical Pharmacology & Therapeutics 113 (5), 963-972, 2023
82023
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
A Bichara, S Gervais, D Le Garrec, P Ouadji, V Sant, S Gosein, V Lemaire, ...
US Patent App. 12/252,117, 2008
7*2008
Modeling and simulation to optimize efficacy and tolerability for once a day trazodone formulation
V Lemaire, C Benquet, D LeGarrec, SD Robertson Sy, SM Stahl
Abstract presented at: The European College of Neuropsychopharmacology meeting, 2009
3*2009
Sample Size Determination and Statistical Hypothesis Testing for Core Centration in Press Coated Tablets
PL de Micheaux, V Lemaire
Open Journal of Statistics 2 (3), 269-273, 2012
12012
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
V Lemaire, C Hu, PH van der Graaf, S Chang, W Wang
Clinical Pharmacology & Therapeutics, 2023
2023
IDENTIFYING BIOLOGICAL SIGNALS DIFFERENTIATING RESPONDERS AND NON-RESPONDERS TO MPDL3280A (ANTI-PDL1) IN NON-SMALL CELL LUNG CANCER USING QUANTITATIVE SYSTEMS PHARMACOLOGY …
V Lemaire, A Rotte, K Gadkar, JY Jin, S Ramanujan
CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S119-S119, 2019
2019
Modélisation de la libération de substances bioactives et des conséquences sur la dynamique physiologique
V Lemaire
University of Montreal, 2003
2003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15